Viremia in acute herpes zoster

A phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster. In this randomized, placebo-controlled, double-blind trial, 25 patients were treated with either sorivudine or placebo cream. All patien...

Full description

Autores:
Satyaprakash, Anita K.
Tremaine, Anne Marie
Stelter, Arwen A.
Creed, Rosella
Ravanfar, Parisa
Mendoza, Natalia
Mehta, Satish K.
Rady, Peter L.
Pierson, Duane L.
Tyring, Stephen K.
Tipo de recurso:
Article of journal
Fecha de publicación:
2009
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/5149
Acceso en línea:
http://hdl.handle.net/20.500.12495/5149
https://doi.org/10.1086/599381
https://repositorio.unbosque.edu.co
Palabra clave:
Herpes zoster
Viremia
Infection
Microbiology
Rights
openAccess
License
Acceso abierto
id UNBOSQUE2_5540514d2249e1680b4bcaefeb78b901
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/5149
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
spelling Satyaprakash, Anita K.Tremaine, Anne MarieStelter, Arwen A.Creed, RosellaRavanfar, ParisaMendoza, NataliaMehta, Satish K.Rady, Peter L.Pierson, Duane L.Tyring, Stephen K.2020-11-30T16:22:45Z2020-11-30T16:22:45Z20091537-6613http://hdl.handle.net/20.500.12495/5149https://doi.org/10.1086/599381instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengOxford University PressThe Journal of Infectious DiseasesThe Journal of Infectious Diseases, 1537-6613, Vol. 200, Nro. 1, 2009 p. 26-32https://academic.oup.com/jid/article/200/1/26/1746157Viremia in acute herpes zosterViremia in acute herpes zosterArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Herpes zosterViremiaInfectionMicrobiologyA phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster. In this randomized, placebo-controlled, double-blind trial, 25 patients were treated with either sorivudine or placebo cream. All patients began 7 days of valacyclovir treatment on day 3. Zoster lesion swab samples and samples of peripheral blood mononuclear cells were collected periodically throughout the study and were analyzed for varicella-zoster virus (VZV) DNA by use of both qualitative and real-time polymerase chain reaction. Serum samples collected periodically throughout the study were analyzed for VZV DNA by use of real-time polymerase chain reaction. VZV DNA was detected in all 3 sample types, and the number of viral copies correlated with the progression of herpes zoster. No statistically significant differences were seen between the placebo- and sorivudine-treated groups with respect to clinical characteristics or laboratory test results. The detection of VZV DNA in the serum and peripheral blood mononuclear cells of all 25 zoster patients documents that viremia is a common manifestation of herpes zoster. Sorivudine cream appears to be a safe and well-tolerated adjuvant therapy; however, further phase 2 studies are needed to determine its clinical efficacy for the treatment of herpes zoster. Trials registration. ClinicalTrials.gov identifier: NCT00652184.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2009-07ORIGINALSatyaprakash_Anita_K_2009.pdfSatyaprakash_Anita_K_2009.pdfapplication/pdf657762https://repositorio.unbosque.edu.co/bitstreams/ffc4340e-d025-4189-916f-839952b6605d/download2ead7a8b81530bd6a0555dbcf0daf4f6MD51THUMBNAILSatyaprakash_Anita_K_2009.pdf.jpgSatyaprakash_Anita_K_2009.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/6bc42d61-bb6c-403f-849e-6299a6c06ddd/download7210a811635d1799e7c05fee5d259be7MD52TEXTSatyaprakash_Anita_K_2009.pdf.txtSatyaprakash_Anita_K_2009.pdf.txtExtracted texttext/plain31605https://repositorio.unbosque.edu.co/bitstreams/fc64ec83-d44c-4f30-aebb-7bf939133fe2/download75914ffbe582345b145e05513e561708MD5320.500.12495/5149oai:repositorio.unbosque.edu.co:20.500.12495/51492024-02-07 11:40:40.823restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.com
dc.title.spa.fl_str_mv Viremia in acute herpes zoster
dc.title.translated.spa.fl_str_mv Viremia in acute herpes zoster
title Viremia in acute herpes zoster
spellingShingle Viremia in acute herpes zoster
Herpes zoster
Viremia
Infection
Microbiology
title_short Viremia in acute herpes zoster
title_full Viremia in acute herpes zoster
title_fullStr Viremia in acute herpes zoster
title_full_unstemmed Viremia in acute herpes zoster
title_sort Viremia in acute herpes zoster
dc.creator.fl_str_mv Satyaprakash, Anita K.
Tremaine, Anne Marie
Stelter, Arwen A.
Creed, Rosella
Ravanfar, Parisa
Mendoza, Natalia
Mehta, Satish K.
Rady, Peter L.
Pierson, Duane L.
Tyring, Stephen K.
dc.contributor.author.none.fl_str_mv Satyaprakash, Anita K.
Tremaine, Anne Marie
Stelter, Arwen A.
Creed, Rosella
Ravanfar, Parisa
Mendoza, Natalia
Mehta, Satish K.
Rady, Peter L.
Pierson, Duane L.
Tyring, Stephen K.
dc.subject.keywords.spa.fl_str_mv Herpes zoster
Viremia
Infection
Microbiology
topic Herpes zoster
Viremia
Infection
Microbiology
description A phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster. In this randomized, placebo-controlled, double-blind trial, 25 patients were treated with either sorivudine or placebo cream. All patients began 7 days of valacyclovir treatment on day 3. Zoster lesion swab samples and samples of peripheral blood mononuclear cells were collected periodically throughout the study and were analyzed for varicella-zoster virus (VZV) DNA by use of both qualitative and real-time polymerase chain reaction. Serum samples collected periodically throughout the study were analyzed for VZV DNA by use of real-time polymerase chain reaction. VZV DNA was detected in all 3 sample types, and the number of viral copies correlated with the progression of herpes zoster. No statistically significant differences were seen between the placebo- and sorivudine-treated groups with respect to clinical characteristics or laboratory test results. The detection of VZV DNA in the serum and peripheral blood mononuclear cells of all 25 zoster patients documents that viremia is a common manifestation of herpes zoster. Sorivudine cream appears to be a safe and well-tolerated adjuvant therapy; however, further phase 2 studies are needed to determine its clinical efficacy for the treatment of herpes zoster. Trials registration. ClinicalTrials.gov identifier: NCT00652184.
publishDate 2009
dc.date.issued.none.fl_str_mv 2009
dc.date.accessioned.none.fl_str_mv 2020-11-30T16:22:45Z
dc.date.available.none.fl_str_mv 2020-11-30T16:22:45Z
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1537-6613
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/5149
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1086/599381
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv https://repositorio.unbosque.edu.co
identifier_str_mv 1537-6613
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
url http://hdl.handle.net/20.500.12495/5149
https://doi.org/10.1086/599381
https://repositorio.unbosque.edu.co
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv The Journal of Infectious Diseases, 1537-6613, Vol. 200, Nro. 1, 2009 p. 26-32
dc.relation.uri.none.fl_str_mv https://academic.oup.com/jid/article/200/1/26/1746157
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2009-07
rights_invalid_str_mv Acceso abierto
http://purl.org/coar/access_right/c_abf2
2009-07
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Oxford University Press
dc.publisher.journal.spa.fl_str_mv The Journal of Infectious Diseases
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/ffc4340e-d025-4189-916f-839952b6605d/download
https://repositorio.unbosque.edu.co/bitstreams/6bc42d61-bb6c-403f-849e-6299a6c06ddd/download
https://repositorio.unbosque.edu.co/bitstreams/fc64ec83-d44c-4f30-aebb-7bf939133fe2/download
bitstream.checksum.fl_str_mv 2ead7a8b81530bd6a0555dbcf0daf4f6
7210a811635d1799e7c05fee5d259be7
75914ffbe582345b145e05513e561708
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814100834067152896